[Desensitization therapy in myocardial infarct].
D000311:Adrenal Glands / Q000503:physiopathology; D000588:Amines / Q000097:blood; D000632:Aminopyrine / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001327:Autoimmune Diseases; D003888:Desensitization, Immunologic; D004155:Diphenhydramine / Q000627:therapeutic use; D004802:Eosinophilia / Q000209:etiology; D006386:Hemagglutination Tests; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000652:urine; D006942:Hypergammaglobulinemia / Q000209:etiology; D006968:Hypersensitivity, Delayed; D008213:Lymphocyte Activation; D009203:Myocardial Infarction / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology / Q000652:urine; D010913:Pituitary-Adrenal System; D011239:Prednisolone / Q000627:therapeutic use; D012769:Shock / Q000209:etiology / Q000652:urine; D012882:Skin Tests
D000588:Amines; D006634:Histamine H1 Antagonists; D000632:Aminopyrine; D004155:Diphenhydramine; D011239:Prednisolone; D001241:Aspirin; D006854:Hydrocortisone
Desensibiliziruiushchaia terapiia pri infarkte miokarda.